Friday, 3 September 2010

Survey suggests cautious welcome for oral MS drugs

From the MS Trust

A survey of American neurologists suggests a cautious welcome for the oral MS drugs currently in development should they be approved.
Of the 75 neurologists questioned, 60% mentioned concerns about side effects and safety issues associated with the emerging treatments. However, 84% recognised that the drugs were more effective than the current treatments and would prescribe them, although they expected they would not be a first-line therapy until concerns about safety were resolved. It was felt that patients would consider them more convenient that the current injections.

For more click here.